Review Article
Human Urine Proteomics: Analytical Techniques and Clinical Applications in Renal Diseases
Table 4
Biomarker candidates for MN discovered by urine proteome analysis.
| Protein biomarkers | Up/downregulation | Cohort | Technique | Type of biomarker | Reference |
| VEGF | ↓ | MN (), minimal change disease (MCD) (), FSGS (), necrotizing glomerulonephritis (), DN (), and healthy control () | ELISA | Diagnostic | [126] |
| β2m | ↑ | iMN () | ELISA | Prognostic-predictive | [127] |
| Nephrin | — | Passive Heymann nephritis (), normal rat () | Western blot | Qualitative diagnostic | [128] |
| LIMP-2 | ↑ | iMN (), FSGS (), and healthy control () | iTRAQ and verification with immunofluorescence of glomeruli | Diagnostic | [104] |
| α1M, URBP | — | Complete remission (CR) (), partial remission (PR) (), limited response (LR) (), and nonresponders (NR) () | Nephelometry | Predictive | [106] |
|
|